Neuroimaging Markers of Midlife Depression and Cognitive Behavioural Therapy (CBT)

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Major Depressive Disorder (MDD)
Interventions
BEHAVIORAL

Cognitive Behavioural Therapy

12 weeks of Cognitive Behavioural Therapy (CBT) will be administered. The first session will be accomplished in-person at Baycrest Hospital. After that, therapy will be conducted virtually, via video-conference. Individuals will undergo therapy once a week for approximately 1 hour, for 12-weeks. Following the 12-week period, individuals will receive three follow-up assessments with their therapist at 3, 6, and 9 months.

Trial Locations (1)

M6A 2E1

Baycrest Hospital, Toronto

All Listed Sponsors
lead

Baycrest

OTHER

NCT07091643 - Neuroimaging Markers of Midlife Depression and Cognitive Behavioural Therapy (CBT) | Biotech Hunter | Biotech Hunter